MBio Diagnostics and BARDA partner on 5-minute, quantitative POC COVID-19 antibody panel

MBio Diagnostics and BARDA partner on 5-minute, quantitative POC COVID-19 antibody panel

BOULDER -- MBio Diagnostics today announced it has been awarded a$629,595contract from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant... Read More

Wednesday June 24, 2020 0 comments Tags: Boulder, MBio Diagnostics, BARDA, COVID-19, Chris Myatt

MBio delivers rapid cytokine test system for COVID-19 research

MBio delivers rapid cytokine test system for COVID-19 research

BOULDER -- MBio Diagnostics today announced delivery to the U.S. Department of Defense with funding for this effort provided by the Defense Health Program throughthe Joint Program Executive Office... Read More

Monday June 15, 2020 0 comments Tags: Boulder, MBio Diagnostics, COVID-19, Chris Myatt

MBio to seek FDA approval for LightDeck platform to more quickly identify deadly viruses

MBio to seek FDA approval for LightDeck platform to more quickly identify deadly viruses

BOULDER -- MBio Diagnostics announced an expanded scope contract with the U.S. Defense Advanced Research Projects Agency (DARPA), where DARPA will apply additional resources and funds to accelerate... Read More

Wednesday April 8, 2020 0 comments Tags: Boulder, MBio Diagnostics, LightDeck, COVID-19, DARPA, Michael Lochhead

MBio Diagnostics announces two new contracts for algae tests

MBio Diagnostics announces two new contracts for algae tests

BOULDER -- MBio Diagnostics, Inc . announced two contracts to develop new tests for algae toxins. The tests will expand the offerings available on MBio's existing platform, the HAB Toxin... Read More

Monday September 23, 2019 0 comments Tags: Boulder, MBio Diagnostics, Mike Lochhead, HAB Toxin System

MBio Diagnostics announces two contracts for sepsis test work

MBio Diagnostics announces two contracts for sepsis test work

BOULDER -- MBio Diagnostics, Inc . announced two new contracts for sepsis test development. The first is a Phase II Small Business Innovative Research grant from the National Institutes of... Read More

Tuesday August 6, 2019 0 comments Tags: Boulder, MBio Diagnostics, Chris Myatt

MBio Diagnostics announces additional $6M in Series B funding

MBio Diagnostics announces additional $6M in Series B funding

BOULDER -- MBio Diagnostics, Inc. announced an additional $6 million in Series B financing led by new and existing investors, including MBios recently announced strategic veterinary partner, ... Read More

Wednesday August 22, 2018 0 comments Tags: Boulder, MBio Diagnostics, Heska, Chris Myatt, LightDeck

MBio Diagnostics announces license partnership with Heska

MBio Diagnostics announces license partnership with Heska

BOULDER -- MBio Diagnostics, Inc. announced a product development partnership and licensing agreement with Loveland-based Heska Corporation (Nasdaq: HSKA), a veterinary diagnostics company... Read More

Thursday May 17, 2018 0 comments Tags: Boulder, MBio Diagnostics, Heska Corporation, Chris Myatt, Kevin Wilson

MBio Diagnostics closes $6.3M Series B round

MBio Diagnostics closes $6.3M Series B round

BOULDER -- MBio Diagnostics Inc ., a provider of rapid clinical diagnostics and sample testing, announced it closed on a $6.3 million Series B financing led by new and existing private investors.... Read More

By: InnovatioNews Tuesday May 26, 2015 0 comments Tags: Boulder, MBio Diagnostics, Chris Myatt